Skip navigation Niven Narain and How AI and Machine Learning are Changing Drug Discovery

Harry Glorikian interviews Niven R. Narain, PhD., Co-Founder, President and CEO of BERG to discuss BERG’s philosophy: to combine a systems biology architecture with patients’ demographic data and clinical outcome data, and then apply Bayesian artificial intelligence algorithms to drive better understanding of diseases.

For the full interview, click here.